- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
8
Companies which are more than 50% undervalued based on analyst price target.
8 companies
Caliway Biopharmaceuticals
Market Cap: NT$168.1b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$108.00
7D
4.3%
1Y
-10.7%
Bora Pharmaceuticals
Market Cap: NT$49.9b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$392.00
7D
3.6%
1Y
-44.4%
Lotus Pharmaceutical
Market Cap: NT$48.9b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$186.00
7D
5.4%
1Y
-17.1%
Oneness Biotech
Market Cap: NT$22.7b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
4743
NT$47.45
7D
8.7%
1Y
-31.1%
TaiMed Biologics
Market Cap: NT$15.7b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$57.60
7D
-0.7%
1Y
-31.6%
Medigen Vaccine Biologics
Market Cap: NT$15.6b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$47.40
7D
1.9%
1Y
9.2%
EirGenix
Market Cap: NT$14.4b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$47.40
7D
3.2%
1Y
-26.2%
Foresee Pharmaceuticals
Market Cap: NT$12.5b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$79.20
7D
-1.9%
1Y
-0.6%